Non-viral mediated gene transfer of porphobilinogen deaminase into mammalian cells

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 62, Issue 2, 2002, Pages 105-113

  Johansson, A ^a   Moller C ^a   Gellerfors, P ^a   Harper, Pauline ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute intermittent porphyria; CMV promoter; Gene therapy; Nonviral; Plasmid DNA; Polyethylenimine; Porphobilinogen deaminase

Indexed keywords

COMPLEMENTARY DNA; HEME; POLYETHYLENEIMINE; PORPHOBILINOGEN DEAMINASE;

ACUTE INTERMITTENT PORPHYRIA; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROID CELL; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HOUSEKEEPING GENE; MOLECULAR CLONING; MOUSE; NEUROPSYCHIATRY; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROMOTER REGION; TIME;

3T3 CELLS; ANIMALS; BLOTTING, WESTERN; CLONING, MOLECULAR; CYTOMEGALOVIRUS; GENE DOSAGE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE THERAPY; HELA CELLS; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; MAMMALS; MICE; MICE, INBRED C57BL; PLASMIDS; POLYETHYLENEIMINE; PORPHYRIA, ACUTE INTERMITTENT; PROMOTER REGIONS (GENETICS); TRANSFECTION;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MAMMALIA; TRIXIS;

EID: 0036105681     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655102753611726     Document Type: Article

References (30)

1. The porphyrias
2. Acute intermittent porphyria increases the risk of liver cancer. Early diagnosis of the cancer and varying surgery may improve the prognosis
3. Hypertension and renal impairment as complications of acute porphyria
4. Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene
5. Molecular cloning and complete primary sequence of human erythrocyte porphobilinogen deaminase
6. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression
7. Therapy of the acute porphyrias
8. Heme therapy
9. Correction of the enzyme deficit of bone marrow cells in congenital erythropoietic porphyria by retroviral gene transfer
10. Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transfer
11. Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell lines
12. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria
13. Congenital erythropoietic porphyria: Prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells
14. Correction of uroporphyrinogen decarboxylase deficiency (hepatoerythropoietic porphyria) in Epstein-Barr virus-transformed B-cell lines by retrovirus-mediated gene transfer: Fluorescence-based selection of transduced cells
15. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy
16. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria
17. 8th Meeting of the European Society of Gene Therapy (ESGT). Stockholm, Sweden, 7-10 October 2000
18. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs
19. The mouse porphobilinogen deaminase gene. Structural organization, sequence, and transcriptional analysis
20. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene
21. Acute intermittent porphyria: Expression of mutant and wild-type porphobilinogen deaminase in COS-1 cells
22. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
23. A red cell enzyme method for the diagnosis of acute intermittent porphyria
24. Physical chemistry composition of blood hematology somatometric data
25. Polyethylenimines: A family of potent polymers for nucleic acid delivery
26. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus
27. Poly(ethylenimine)-mediated transfection: A new paradigm for gene delivery
28. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold
29. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery
30. Polyethylenimine-mediated gene delivery: A mechanistic study